GlobeNewswire: Khiron Life Sciences Corp. Contains the last 10 of 18 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T01:11:42ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2021/03/11/2191406/0/en/Khiron-Life-Sciences-Corp-To-Present-At-The-Q1-Virtual-Investor-Summit.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit2021-03-11T13:30:00Z<![CDATA[TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announced that Alvaro Torres, CEO, will be attending the Q1 Virtual Investor Summit.]]>https://www.globenewswire.com/news-release/2020/11/26/2134621/0/en/Khiron-Life-Sciences-Announces-Closing-of-14-49-Million-Bought-Deal-Financing-Including-Full-Exercise-of-Over-Allotment-Option.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Announces Closing of $14.49 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option 2020-11-26T13:56:34Z<![CDATA[NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES]]>https://www.globenewswire.com/news-release/2020/11/23/2131908/0/en/Khiron-Life-Sciences-Re-Files-Q2-2020-Interim-Financial-Statements-to-Correct-Comparative-Disclosure-and-Certain-Presentation.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Re-Files Q2 2020 Interim Financial Statements to Correct Comparative Disclosure and Certain Presentation2020-11-23T14:00:00Z<![CDATA[TORONTO, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or, the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “Interim Financial Statements”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.]]>https://www.globenewswire.com/news-release/2020/07/21/2065299/0/en/Khiron-Announces-Change-of-Auditor.html?f=22&fvtc=4&fvtv=38863Khiron Announces Change of Auditor2020-07-21T20:02:00Z<![CDATA[TORONTO, July 21, 2020 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), announces that MNP LLP (the “Former Auditor”) have, at the request of the Company, resigned as auditors of the Company, effective July 10, 2020. Accordingly, the Board of Directors has appointed BDO Canada LLP (the “Successor Auditor”) as auditors of the Company.]]>https://www.globenewswire.com/news-release/2018/12/20/1670406/0/en/Uptick-Newswire-Hosts-Khiron-Life-Sciences-Corp-s-President-to-Discuss-the-Growing-Latin-American-Cannabis-Market-and-How-They-Have-Positioned-Themselves-as-a-Leader.html?f=22&fvtc=4&fvtv=38863Uptick Newswire Hosts Khiron Life Sciences Corp.’s President to Discuss the Growing Latin American Cannabis Market and How They Have Positioned Themselves as a Leader2018-12-20T14:00:00Z<![CDATA[PHOENIX, Dec. 20, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast features Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: 4KH), an integrated medical cannabis company with its core operations in Colombia. President of the company, Chris Naprawa, talked with Stock Day’s Everett Jolly.]]>https://www.globenewswire.com/news-release/2018/12/13/1666622/0/en/Khiron-Life-Sciences-Completes-Acquisition-of-ILANS.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Completes Acquisition of ILANS2018-12-13T13:30:00Z<![CDATA[Acquisition of ILANS, Colombia’s leading health network, provides Khiron with direct access to a network of 100,000 patients Acquisition of ILANS, Colombia’s leading health network, provides Khiron with direct access to a network of 100,000 patients]]>https://www.globenewswire.com/news-release/2018/11/29/1659743/0/en/Khiron-Life-Sciences-Reports-Third-Quarter-Fiscal-2018-Financial-Results.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Reports Third Quarter Fiscal 2018 Financial Results2018-11-29T23:15:13Z<![CDATA[TORONTO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQB: KHRNF) (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today its financial results for the third quarter ended September 30, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com]]>https://www.globenewswire.com/news-release/2018/08/21/1554753/0/en/Khiron-Announces-Filing-of-Marketed-Short-Form-Prospectus-Offering-of-Common-Shares.html?f=22&fvtc=4&fvtv=38863Khiron Announces Filing of Marketed Short Form Prospectus Offering of Common Shares2018-08-21T17:21:29Z<![CDATA[Not for Distribution to U.S. Newswire Services or Dissemination in the United States]]>https://www.globenewswire.com/news-release/2018/05/18/1509041/0/en/Khiron-Life-Sciences-Corp-Formerly-Adent-Capital-Corp-Completes-Qualifying-Transaction.html?f=22&fvtc=4&fvtv=38863Khiron Life Sciences Corp. (Formerly Adent Capital Corp.) Completes Qualifying Transaction2018-05-18T20:10:05Z<![CDATA[Not for distribution to U.S. Newswire Services or for dissemination in the United States.]]>https://www.globenewswire.com/news-release/2018/05/16/1504025/0/en/Adent-Capital-Corp-Announces-Filing-of-Filing-Statement-for-its-Qualifying-Transaction.html?f=22&fvtc=4&fvtv=38863Adent Capital Corp. Announces Filing of Filing Statement for its Qualifying Transaction2018-05-16T01:04:47Z<![CDATA[Not for distribution to U.S. Newswire Services or for dissemination in the United States.]]>